Australia-based digital therapeutics startup Mindset Health has unveiled its latest digital therapeutics offering to help people quit smoking within a month.
Founded in 2018, Mindset Health is building a range of hypnosis-based DTx apps. Its first product, Nerva, is a digital hypnotherapy solution for treating irritable bowel syndrome.
WHAT IT'S ABOUT
Its latest offering is a DTx app that uses...
When it comes to privacy and data transparency, smoking cessation and depression apps fall short, according to a new study published in JAMA this morning. The study, which zeroed in on 36 apps, found that 33 of those apps transmitted data to a third party. However, 17 of those apps either “lacked a privacy policy, failed to disclose the transmission policy in text or said that the transmission...
Delving into device data. This year UnitedHealthcare will be expanding its Navigate4Me service for Medicare Advantage plan participants using data collected through digital devices, the payer announced today. Specifically, these data will be processed through the UnitedHealthcare Nerve Center and used to flesh out patient profiles, allowing navigators to provide support for congestive heart...
Carrot, the Redwood City, California-based maker of a smoking cessation app and its paired, FDA-cleared breathalyzer device, announced this week that it has raised $25 million in new funding. The investment was led by Johnson & Johnson Innovation (JJDC), with participation from New York Life Ventures, Khosla Ventures, Marc Benioff, R7 Partners and Dr. David Utley, Carrot’s founder, president...
Redwood City, California-based Carrot has received FDA 510(k) clearance for its Carbon Monoxide Breath Sensor System, an over-the-counter, Bluetooth-enabled device that pairs with a smartphone app and is intended for commercial use in smoking cessation programs.
“Smoking is the number one cause of preventable illness and death worldwide,” Dr. David S. Utley, founder and CEO of Carrot, said in a...
While strategies ranging from cold turkey to scare tactics and stop-gap solutions like gum abound, smoking remains among the most notoriously difficult habits to kick. That’s why MindCotine, a Redwood City, California-based startup wants to tackle the issue with a novel new technology: virtual reality.
Smoking is more than a physiological need, the Argentina-born cofounders Cristian Waitman,...
Digital smoking cessation company 2Morrow has partnered with GlaxoSmithKline, makers of Nicoderm patches, to offer the company’s Nicoderm CQ Patch to smokers who complete 2morrow’s cessation program.
2Morrow’s smoking cessation app, called SmartQuit, is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept the physical, mental...
The National Cancer Institute (NCI) has awarded Chrono Therapeutics a Small Business Innovation Research (SBIR) grant of up to $2.3 million for product development of the digital portion of the company's smoking cessation therapy offering. The new grant will fund Chrono's final clinical trial for its product.
This is the second grant Chrono has received from the NCI. The first, $2.23 million...
The National Cancer Institute has awarded Jonathan Bricker, a behavioral scientist and faculty member at Fred Hutchinson Cancer Research Center, with a five-year, $3.1 million grant to conduct a randomized controlled trial of SmartQuit, a smoking-cessation app.
SmartQuit is based on acceptance and commitment therapy, or an ACT-based program, that "focuses on increasing one’s willingness to accept...
Seattle-based behavior change company 2Morrow has launched an app, called SmartQuit, that aims to help smokers quit.
2Morrow partnered with the Fred Hutchinson Cancer Research Center to create the app. In October, 2Morrow published a randomized control trial of 196 participants and found that users of SmartQuit were 2.5 to 3 times more likely to quit than those who try to quit on their own. The...
